Problems and Modern Possibilities of Myocardial Infarction Diagnostics

A.M. Kravchenko, V.S. Pasko

Abstract


Due to the fact that the detection of myocardial infarction in Ukraine is extremely inadequate, contemporary features and new biochemical methods for studying this disease and to optimize diagnostic prospects at different stages of care had been analyzed.


Keywords


acute coronary syndrome; myocardial infarction; diagnosis; cardiac troponins

References


Коваленко В.М., Корнацький В.М. Динаміка стану здоров’я народу України та регіональні особливості / В.М. Коваленко, В.М. Корнацький. — К., 2012. — 212 с.

Пархоменко О.М., Лутай Я.М., Даншан Н. Украинский регистр острого инфаркта миокарда как фрагмент Европейского: характеристика больных, организация медицинской помощи и госпитальная терапия // Український медичний часопис. — 2011. — № 1. — С. 20-24.

Alpert J.S., Thygesen K., Antman E., Bassand J.P. Myocardial infarction redefined — a consensus document of The Joint European Society of Cardiology / American College of Cardiology Committee for the redefinition of myocardial infarction / J.S. Alpert, K. Thygesen, E. Antman, J.P. Bassand // J. Am. Coll. Cardiol. — 2000. — № 36(3). — Р. 959-969.

ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine / J.L. Anderson, C.D. Adams, E.M. Antman [et al.] // J. Am. Coll. Cardiol. — 2007. — № 50(7). — e1-e157.

Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction / F.S. Apple, C.A. Parvin, K.F. Buechler [et al.] // Clin. Chem. — 2005. — № 51(11). — Р. 2198-2200.

Eggers K.M., Oldgren J., Nordenskjöld A., Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction / K.M. Eggers, J. Oldgren, A. Nordenskjöld, B. Lindahl // Am. Heart J. — 2004. — № 148(4). — Р. 574-581.

Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies / A.R. Macrae, P.A. Kavsak, V. Lustig [et al.] // Clin. Chem. — 2006. — № 52(5). — Р. 812-818.

Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction / P.A. Kavsak, A.R. MacRae, A.M. Newman [et al.] // Clin. Chim. Acta. — 2007. — № 380(1–2). — Р. 213-216.

Saenger A.K., Jaffe A.S. Requiem for a heavyweight: the demise of creatine kinase–MB / A.K. Saenger, A.S. Jaffe // Circulation. — 2008. — № 118(21). — Р. 2200-2206.

Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee / E.M. Antman, M. Hand, P.W. Armstrong [et al.] // Circulation. — 2008. — № 117(2). — Р. 296-329.

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes / E.M. Antman, M.J. Tanasijevic, B. Thompson [et al.] // N. Engl. J. Med. — 1996. — № 335(18). — Р. 1342-1349.

The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis / P.A. Heidenreich, T. Alloggiamento, K. Melsop [et al.] // J. Am. Coll. Cardiol. — 2001. — № 38(2). — Р. 478-485.

Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study / M.C. Iliou, C. Fumeron, M.O. Benoit [et al.] // Am. J. Kidney Dis. — 2003. — № 42(3). — Р. 513-523.

Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators / E.M. Ohman, P.W. Armstrong, R.H. Christenson [et al.] // N. Engl. J. Med. — 1996. — № 335(18). — Р. 1333-1341.

Prognostic significance of admission troponin T concentrations in patients with myocardial infarction / P. Stubbs, P. Collinson, D. Moseley [et al.] // Circulation. — 1996. — № 94(6). — Р. 1291-1297.

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease / B. Lindahl, H. Toss, A. Siegbahn [et al.] // N. Engl. J. Med. — 2000. — № 343(16). — Р. 1139-1147.

Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators / L.K. Newby, R.H. Christenson, E.M. Ohman [et al.] // Circulation. — 1998. — № 98(18). — Р. 1853-1859.

Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group / B. Lindahl, P. Venge, L.Wallentin // Circulation. — 1996. — № 93(9). — Р. 1651-1657.

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide / M.S. Sabatine, D.A. Morrow, J.A. de Lemos [et al.] // Circulation. — 2002. — № 105(15). — Р. 1760-1763.

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia / M.S. Sabatine, D.A. Morrow, J.A. de Lemos [et al.] // J. Am. Coll. Cardiol. — 2004. — № 44(10). — Р. 1988-1995.

Association between myeloperoxidase levels and risk of coronary artery disease / R. Zhang, M.L. Brennan, X. Fu [et al.] // JAMA. — 2001. — № 286(17). — Р. 2136-2142.

Prognostic value of myeloperoxidase in patients with chest pain / M.L. Brennan, M.S. Penn, F. Van Lente [et al.] // N. Engl. J. Med. — 2003. — № 349(17). — Р. 1595-1604.

Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome / F.S. Apple, A.H. Wu, J. Mair [et al.] // Clin. Chem. — 2005. — № 51(5). — Р. 810-824.

Apple F.S., Smith S.W., Pearce L.A., Murakami M.M. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome / F.S. Apple, S.W. Smith, L.A. Pearce, M.M. Murakami // Clin. Chem. — 2009. — № 55(1). — Р. 93-100.

Abadie J.M., Blassingame C.L., Bankson D.D. Albumin cobalt binding assay to rule out acute coronary syndrome / J.M. Abadie, C.L. Blassingame, D.D. Bankson // Ann. Clin. Lab. Sci. — 2005. — № 35(1). — Р. 66-72.

Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department / F. Peacock, D.L. Morris, S. Anwaruddin [et al.] // Am. Heart J. — 2006. — № 152(2). — Р. 253-262.

Role of Ischemia modified albumin, a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes / M.K. Sinha, D. Roy, D.C. Gaze [et al.] // Emerg. Med. J. — 2004. — № 21(1). — Р. 29-34.




DOI: https://doi.org/10.22141/2224-0586.2.49.2013.90468

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 EMERGENCY MEDICINE

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru